A5035065734- Vaccine Coverage and Hesitancy
- Vascular anomalies and interventions
- Parathyroid Disorders and Treatments
- Parasites and Host Interactions
- Misinformation and Its Impacts
- Ureteral procedures and complications
- Global Maternal and Child Health
- Medical Imaging and Pathology Studies
- Caveolin-1 and cellular processes
- Abdominal vascular conditions and treatments
- Gastroesophageal reflux and treatments
- COVID-19 and Mental Health
Al-Quds University
2021-2025
Abstracts Ascaris lumbricoides is one of the most well-known helminthic parasites affecting humans. Ascariasis prevalent in developing countries where inadequate water, sanitation, and hygiene facilitate human-to-human transmission. In this report, we present a case 20-year-old male who arrived at emergency room with severe right flank pain, high-grade fever, recurrent vomiting. Diagnostic evaluations were conducted, including complete blood test (CBC), urinalysis, stool analysis, abdominal...
COVID-19 is an emerging respiratory disease caused by a novel coronavirus accompanied tsunami of misinformation and fake news. This can weaken the public health responses affecting COVID-19-related knowledge, attitudes, practices (KAP) public. Therefore, this cross-sectional study was designed during early stage pandemic to evaluate KAP Palestinian university students their commonly used information sources. We found that most trusted source among World Health Organization (WHO), followed...
Chronic mesenteric ischemia (CMI) is a rare cause of abdominal pain with risk factors as Diabetes, Hypertension, smoking and age above 65-year-old age. A 55 -year-old man, heavy smoker, no other factor for chronic ischemia, presented recurrent episodes pain. Many differential diagnoses were excluded, CT angiography was showed Inferior Mesenteric artery (IMA) superior (SMA) stenosis, then the Intervention done successful. Gastric ulcers that are resistant to treatment, H. pylori negative...
Hyperphosphatemia familial tumoral calcinosis (HFTC) and hyperphosphatemia hyperostosis syndrome (HHS) are rare autosomal recessive disorders caused by mutations in the polypeptide N-acetylgalactosaminyltransferase 3 (GALNT3), fibroblast growth factor 23 (FGF23), or klotho (KL) genes. They characterized recurrent episodes of bone lesions with and/or soft tissue calcinosis. Management options include phosphate-lowering therapies, anti-inflammatory medications, surgical excision calcified...